<DOC>
	<DOCNO>NCT02336672</DOCNO>
	<brief_summary>In patient locally advance tumour , neoadjuvant treatment propose various modality way decrease size downstage tumour lead re-sectable disease . The HybridTherm probe ( HTP ) , ( ERBE Elektromedizin GmbH , Tübingen , Germany ) com-bines bipolar RF-ablation cryogenic induce cooling . It well known bipolar radiofrequency system create ablation less collateral thermal damage standard monopolar system trade-off lose overall efficiency .</brief_summary>
	<brief_title>EUS-Guided Cryothermal Ablation Patients With Stage III Pancreatic Adenocarcinoma ( HybridTherm Study )</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>pathological diagnosis patient borderline resectable/locally advanced pancreatic adenocarcinoma ; patient previously treat neoadjuvant treatment , irrespective regimen age &gt; 18 year ; ≤ 75 gender eligible study : patient express consent Karnofsky Performance status &gt; 70 ; Life expectancy &gt; 6 month . PLT &gt; 100000/mcl ; INR &lt; 1.5 . adequate renal function creatinine threshold adequate bone marrow function ( WBC ≥3500 ) pregnancy acute pancreatitis patient distant metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pancreatic adenocarcinoma</keyword>
	<keyword>Cryothermoablation</keyword>
</DOC>